BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2009
View Archived Issues
Phase III study adds to evidence for milnacipran in fibromyalgia
Read More
Oral parathyroid hormone treatment appears feasible
Read More
Four-year COMBAT data show BPH improvement with Duodart
Read More
CSIR discloses naphthalimide-benzimidazole hybrids for the treatment of cancer
Read More
O2h 10/08 identified as potential candidate for the treatment of AD
Read More
Merck & Co claims angiotensin receptor antagonists for the treatment of hypertension
Read More
Preclinical evaluation of novel nAChR agonist CP-810123 disclosed by Pfizer
Read More
Meloxicam is an effective treatment for refractory nocturia in BPH patients
Read More
Pre-liver transplant therapy with PEG/RBV reduces HCV recurrence
Read More
Gruenenthal describes B1 receptor antagonists for the treatment of pain
Read More
Allergan presents EP2 receptor agonists for the treatment of glaucoma
Read More
Nabi Biopharmaceuticals starts phase III trial of NicVAX as an aid to stop smoking
Read More
Ironwood and Forest report results of two phase III linaclotide trials in constipation
Read More
AFM grants Santhera award for nonclinical trials of omigapil for CMD
Read More
Xoma and Kaketsuken sign agreement for antibody research and development
Read More
SurModics and NuPathe sign license agreement for drug delivery technology in PD
Read More
Adeona starts controlled trial of Zinthionein oral zinc therapy for Alzheimer's disease
Read More
Antigenics reports results from third quarter of 2009
Read More
Canadian marketing approval for BioMimetic Therapeutics' Augment Bone Graft
Read More
Idenix initiates phase II clinical trial of IDX-184 in patients with HCV
Read More
FDA and European Commission grant orphan drug status to Zeltia's Nypta for PSP
Read More
MediciNova initiates phase Ib clinical trial of MN-221 in moderate to severe COPD
Read More
PAION reports results from phase IIa trial of CNS-7056 in upper GI endoscopy
Read More
Tolera Therapeutics files IND with FDA for TOL-101 to prevent organ transplant rejection
Read More
GSK continues enrollment in phase III trial of malaria vaccine with QS-21adjuvant
Read More
BioCryst's partner Shionogi files NDA for peramivir in Japan
Read More